Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

31.27
Delayed Data
As of 3:59pm ET
 -1.20 / -3.70%
Today’s Change
20.07
Today|||52-Week Range
34.06
+10.53%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close32.47
Today’s open32.08
Day’s range30.48 - 32.66
Volume238,258
Average volume (3 months)267,323
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+58.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio156.4
Price/Sales11.37
Price/Book8.72

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-1.55-4.93%
PTLAPortola Pharmaceutic...-0.86-4.53%
EBSEmergent BioSolution...-1.25-4.50%
SUPNSupernus Pharmaceuti...-0.50-2.18%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs